ClinicalTrials.govpublic full text
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant
herpes zoster, immunocompromised, safety, ≥ 18 years of age, renal transplant, adults, immunosuppressed, immunogenicity, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 911065
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.